SciBac

04/02/2022

Congrats to the whole SciBac team for winning TWO Biotechnology Awards from Global Health & Pharma -- Best Antibiotic Resistant Disease Therapeutics Company - USA
Best Pseudomonas Aeruginosa Prevention Biotherapeutic 2022: Aeruguard
https://www.ghp-news.com/winners/scibac/


Kudos Jeanette Sattler Mucha!

03/07/2022

Join us at the World’s First Microbiome & Multi-Omics (M&M) Virtual Conference March 8-9 put together by the 20/15 Visioneers! Our CEO Jeanette Sattler Mucha will be presenting this Wednesday at 2:30pET/11:30a PT and will be available to answer questions as part of the Vendor Showcase at 9a & 12:30p PT both tomorrow and Wednesday.

https://20visioneers15.com/events

Thought Leaders in Management Consulting & Marketing

12/28/2021

SciBac wishes you a Happy Holidays and a wonderful New Year filled with health and joy!

11/14/2021

SciBac's Jeanette Sattler Mucha is pitching at 2:10p PST tomorrow! We will be one of many diverse companies that will be pitching from all around the world at Newchip’s Online Demo Week.

Click the link to RSVP for Demo Week and get free access to the entire event! Can’t watch us live? Register below to receive on-demand access after Online Demo Week! https://www.eventbrite.com/e/newchips-november-2021-online-demo-week-tickets-175733312067?aff=ncp1121
*
*
*

The Newchip Accelerator cordially invites you to attend its November 2021 Online Demo Week!

11/10/2021

Newchip’s Online Demo Week is next week! We’re really excited to be participating this Fall and are looking forward to pitching, engaging with investors, and listening to speakers and thought leaders in our industry.

Jeanette Sattler Mucha will be sharing our current pitch with viewers to gather feedback, learn from leaders in the startup ecosystem, and ultimately connect with investors who are seeking new funding opportunities. This entirely free digital event will be taking place from November 15th-19th. Our pitch will air as part of the Life Sciences & Healthcare block on MONDAY at 2:10p PST.

Even if you can’t watch live, all registered investors will receive access to all pitches on-demand. Click the event link below to register:
https://lnkd.in/eTd4kDSr

Can’t wait to see you there!

The Newchip Accelerator cordially invites you to attend its November 2021 Online Demo Week!

04/20/2021

SciBac CEO Jeanette Sattler Mucha is presenting tomorrow at 11:40a as part of the Anti-Infective Drug Development Summit panel on Exploring Non-Traditional Approaches to Combat Multi-Drug Resistance. Join us for her riveting presentation on:
• SciBac's first-in-class approach of delivering beneficial bacteria directly into the lungs to fight chronic bacterial infections in cystic fibrosis & beyond
• SciBac’s MERGE platform allows strains to be patented yet still non- GMO with faster development and a low cost of goods
• SciBac’s multiple mechanisms (anti-bacterials, mucolytic action, biofilm removal, anti-inflammatory) to increase efficacy and decrease pathogen resistance

Prioritize Anti-Infective Drug Development Pipelines that Focus on High Value Clinical Candidates, Novel Modalities & Effective Strategies that Address Market Sustainability & Aim for Superiority

03/12/2021

See our CEO Jeanette Mucha present at Capital Call – Life Sciences where innovation meets capital on Tue, March 30 at 8:45a PT. Request your invitation today by emailing [email protected]
https://www.cooley.com/events/2021/2021-03-30-capital-call-life-sciences

Share this Capital Call – Life Sciences Where innovation meets capital Tuesday, March 30, 2021 • 11:45 am – 1:30 pm Eastern Time Virtual event Capital Call connects investors to high-potential companies. This highly anticipated program consistently attracts an audience of 200+ VCs and accredit...

12/21/2020

Happy Holidays from SciBac! Wishing you good health in 2021.

11/17/2020

SciBac among the top 7% of applicants selected to present at the Qb3 tomorrow! In the age of covid, investors understand how important it is to support new modalities that fight infectious disease.

11/15/2020

Join us virtually this Wednesday, Nov 18th Qb3's Pitch Summit, where we have been awarded a coveted spot to share our exciting new developments in treating antibiotic resistant lung disease with our multi-modal live ! https://qb3.org/pitch-summit

QB3 Pitch Summit The QB3 Pitch Summit introduces accredited life science investors to startups who are looking for funding from early-stage through Series A.

06/09/2020

SciBac is focused on becoming the new standard of care for chronic infections, circumventing the pitfalls of the antibiotics.

https://biotechconnectionbay.org/viewpoint/resistant-to-antibiotic-resistance/

Ultimately, this economic model is hard for companies to generate enough revenue to continue to operate. Delinking this model aims to pay for antibiotics based on social value, not volume of drug used.

06/03/2020

Don't miss our CEO Jeanette Sattler Mucha speak at TOMORROW's SynBioBeta's Built with Biology - The Bioeconomy Summit, on the "Synthetic Biology Innovation Pipeline" panel at 9am.

Register now (free) to attend virtually.

https://hopin.to/events/built-with-biology-8aab1486-80a0-4b9b-b9aa-ad3ca7081e68

As biology ravages the global economy, let’s rethink normal and set a new standards. Together, we can shape how biology will rebuild the global economy stronger and more sustainably. Right now, we have a trillion-dollar opportunity to redefine the...